Ferring Pharmaceuticals

Ferring Pharmaceuticals is a privately-owned biopharmaceutical company founded in 1950 in Malmö, Sweden. The company is dedicated to developing innovative therapies that support family building, health maintenance, and disease management. Ferring focuses on key therapeutic areas such as reproductive medicine and maternal health, gastroenterology, orthopaedics, and microbiome research. Ferring offers a comprehensive portfolio of products, including Zomacton, a growth hormone, and Euflexxa, a hyaluronic acid treatment for osteoarthritis pain. With a presence in over 100 countries and operating subsidiaries in more than 50, Ferring reaches millions of patients globally. The company invests significantly in research and development, committing 15% of its global revenue to advance scientific innovation and create new therapeutic solutions. Ferring's leadership fosters a dynamic work environment and emphasizes community support through various initiatives.